Factors predictive of response to interferon‐α therapy in hepatitis C virus infection

Hepatology

Volumn 19, Issue 5, 1994, Pages 1088-1094

  Tsubota, Akihito ^a   Chayama, Kazuaki ^a   Ikeda, Kenji ^a   Yasuji, Arase ^a   Koida, Isao ^a   Saitoh, Satoshi ^a   Hashimoto, Michiyo ^a   Iwasaki, Satomi ^a   Kobayashi, Mariko ^a   Hiromitsu, Kumada ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; AGED; BASE SEQUENCE; CHRONIC DISEASE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REMISSION INDUCTION; VIREMIA;

EID: 0028204083     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840190505     Document Type: Article

References (22)

1. Isolation of a cDNA clone derived from a blood‐borne non‐A, non‐B viral hepatitis genome
2. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis
3. There are two major types of hepatitis C virus in Japan
4. Typing of hepatitis C virus genomes by restriction fragment length polymorphism
5. Typing hepatitis C virus by polymerase chain reaction with type‐specific primers: application to clinical surveys and tracing infectious sources
6. Full‐length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes
7. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants
8. Treatment of chronic non‐A, non‐B hepatitis with recombinant human alpha interferon
9. Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double‐blind, placebo‐controlled trial
10. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial
11. Clinical backgrounds of the patients having different types of hepatitis C virus genomes
12. Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐α therapy: relationship to genotypes of hepatitis C virus
13. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
14. Quantitative analysis of hepatitis C virus RNA by competitive nested polymerase chain reaction
15. Avoiding false positives with PCR
16. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction
17. Genotypic subtyping of hepatitis C virus
18. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients
19. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections
20. Comparison of 1 or 3 MU of interferon alfa‐2b and placebo in patients with chronic non‐A, non‐B hepatitis
21. Differences in the hepatitis C virus genotypes in different countries